Interleukin 1β, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: A potential mechanism of macrolide therapy

Respiration

Volumn 63, Issue 1, 1996, Pages 42-48

  Sakito, Osamu ^a   Kadota, Jun Ichi ^a   Kohno, Shigeru ^a   Abe, Koh ^a   Shirai, Ryo ^a   Hara, Kohei ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bronchoalveolar lavage fluid; Cytokine levels; Diffuse panbronchiolitis; Interleukin 1 ; Interleukin 8; Macrolide antibiotics; Tumor necrosis factor alpha

Indexed keywords

CYTOKINE; ERYTHROMYCIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; MACROLIDE; ROXITHROMYCIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD LEVEL; BRONCHIOLITIS; CELL LEVEL; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MALE; NEUTROPHIL; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADULT; BRONCHIOLITIS; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-8; MACROLIDES; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030070464     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000196514     Document Type: Article

References (31)

1. Homma H. Yamanaka A. Tanimoto S. Tamura M. Chijimalsu Y, Kira S. Izumi T: Diffuse panbronchiolitis: A disease of the transitional zone of the lung. Chest 1983:83:63-69.
2. Kudoh S, Uetake T. Hagiwara K. Hirayama M. IIus LH, Kimura H. Sugivama Y: Clinical effect of low-dose long-term erythromycin chemotherapy on diffuse panbronchiolitis. Jpn J Thorac Dis 1987:25:632-642.
3. Yamamoto M. Kondo A. Tamura A. Izumi T, Ina Y. Noda M: Long-term therapeutic effects of erythromycin and new quinolone antibacterial agents on diffuse panbronchiolitis. Jpn J Thorac Dis 1990;28:1305-1313.
4. Ashitani J. Doutsu Y. li T. Taniguchi H. Mat-sukura S: A case of diffuse panbronchiolitis relieved by the treatment of roxithromycin. J Jpn Assoc Infect Dis 1992:66:657-658.
5. Nelson S. Summer WR. Terry PB. Warr GA. Jakab GJ: Erythromycin-induced suppression of pulmonary antibacterial defenses: A potential mechanism of superinfection in the lung. Am Rev RespirDis 1987:136:1207-1212.
6. Goswami SK. Kivity S, Marom J: Erythromycin inhibits respiratory glycoconjugate secretion from human airways in vitro. Am Rev RespirDis 1990:141:72-78.
7. Kadota J, Oda H, Sakito O. Savva H. Morikawa N. Mukae H. Senju R, Tomono K. Fukushima K. Hiratani K. Yokoyama A. Komori K. Ya-maguchi K. Hirota M, Hara K: Effect of erythromycin on neutrophil function in chronic respiratory tract disease with Pseudomonas infection. J Jpn.Assoc Infect Dis 1991:65:277-285.
8. Katahira J. Ilaruki K. Shibata Y. Hasegawa H. Totsuka K, Shimizu K: Kinetic studies on the effect of macrolide on cytokine production. Chemotherapy 1991:39:678-686.
9. Mikami M: Clinical and pathophysiological significance of neutrophil elastase in sputum and the effect of erythromycin in chronic respiratory diseases. Jpn J Thorac Dis 1991:29:72-83.
10. Kadota J. Sakito O. Kohno S. Savva H, Mukae H, Oda H, Kavvakami K, Fukushima K. Ilira-tani K, Hara K: A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis: Am Rev Respir Dis 1993; 147:153-159.
11. Baggiolini M. Walz A, Kunkel SL: Neutrophilactivating peptide-l/interleukin-8, a novel cytokine that activates neutrophils. J Clin Invest 1989:84:1045-1049.
12. Sylvester I. John AR. Yoshimura T. Tanaka S. Leonard EJ: Secretion of neutrophil attractanl/ activation protein by lipopolysaccharide-stim-ulaled lung macrophages determined by both enzyme-linked immunosorbent assay and N-terminal sequence analysis. Am Rev Respir Dis 1990:141:683-688.
13. Kunkel SL. Standiford T. Kasahara K. Stricter RM: Interleukin-8 (IL-8): The major neutrophil chemotactic factor in the lung. Exp Lung Res 1991:17:17-23.
14. Ichikawa Y. Koga H, Tanaka M. Nakamura M. Tokunaga N. Kaji M: Neutrophilia in bron-choalveolar lavage fluid of diffuse panbronchiolitis. Chest 1990:98:917-923.
15. Kindt GC. Weiland JE. Davis WB. Gadek JE. Dorinsky PM: Bronchiolitis in adults: A reversible cause of airway obstruction associated with airway neutrophils and neutrophil products. Am Rev Respir Dis 1989:140:483-492.
16. Ninomiya H. Ichikawa Y. Koga H. Yano T. Oizumi K: Elastase activity in bronchoalveolar lavage fluid from patients with diffuse panbronchiolitis. J Jpn.Assoc Infect Dis 1991:65: 672-680.
17. Larsen CG. Anderson AO. Appella E. Oppenheim H, Matsushima K: The neutrophil-activating protein (NAP-1) is also chemotactic for lymphocytes. Science 1989:243:1045-1047.
18. Slrieter RM. Phan SH, Showell HJ. Rernick DG. Lynch JP. Genord M. Raiford C, Eskan-dari M, Marks RM, Kunkel SL: Monokine-induced neutrophil chemotactic factor gene expression in human fibroblasts. J Biol Chem 1989:264:10621-10626.
19. Miller EJ. Cohen AB. Nagao S. Griffith D. Maunder RH, Martin TR, Weiner-Kronish JP. Sticherling M, Cristophers E, Matthay MA: Elevated levels of NAP-l/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev RespirDis 1992:146:427-432.
20. Donnelly SC. Stricter RM. Kunkel SL. Walz A. Robertson CR. Carter DC. Grant IS. Pollok AJ, Haslett C: Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 1993:341:643-647.
21. Lynch JP III. Standiford TJ. Rolfe MW. Kunkel SL. Stricter RM: Neutrophilic alveolitis in idiopathic pulmonary fibrosis: The role of interleukin-8. Am Rev Respir Dis 1992:145: 1433-1439.
22. Hyers TM. Tricomi SM. Dettenmeier PA, Fowler AA: Tumor necrosis factor levels in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1991:144:268-271.
23. Suter PM. Sutcr S. Girardin E. Roux-Iombard P, Grau GE. Dayer J: High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory' distress syndrome after trauma, shock, or sepsis. Am Rev RespirDis 1992:145:1016-1022.
24. Kelly J: Cytokines of the lung: State of the art. Am Rev Respir Dis 1990;141:765-788.
25. Mikasa K. Sawaki M. Kita E. Konishi M. Mae-da K, Hamada K. Takeuchi S. Masutani T. Sano R. Kunintatsu M. Kashiba S, Narita N: Long-term chemotherapy using erythromycin (EM) for chronic lower airway infection: Effectiveness of clarithromycin in EM ineffective cases. J Jpn Assoc Infect Dis 1992:66:1097-1104.
26. Takeda H. Oogaki N. Kikuchi N. Kobayashi H: A study to clarify the mechanism of the usefulness of the macrolides: The influence of clarithromycin to biofilnt with Pseudomonas aeruginosa. J Jpn Assoc Infect Dis 1992:66:1454-1461.
27. Konno S. Adachi M. Asano K, Kawazoe T. Okamoto K. Takahashi T: Influences of roxithromycin on cell-mediated immune responses. Life Sci 1992;51:107-112.
28. Sakito O. Kadota J. Kusano S. Morikawa T. Kolimr S, Hara K: Effect of erythromycin on neutrophil chemotactic activity from human monocytes. J Jpn Assoc Infect Dis 1993:67: 598-599.
29. Bazzoni F. Cassatella MA. Rossi F. Ceska M, Dewald B. Baggiolini M: Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide I/interleukin 8. J Exp Med 1991;173:771-774.
30. Tiku K. Tiku ML. Skosey JL: Interleukin I production by human polymorphonuclear neutrophils. J Immunol 1986:136:3677-3685.
31. Marucha PT. Zeff RA. Kreutzer DL: Cytokine-induced IL-1 gene expression in the human polymorphonuclear leukocyte: Transcriptional and posttranscriptional regulation by tumor necrosis factor and IL-1. J Immunol 1991; 147: 2603-2608.